166 related articles for article (PubMed ID: 16763682)
1. Structure-activity studies on a library of potent calix[4]arene-based PDGF antagonists that inhibit PDGF-stimulated PDGFR tyrosine phosphorylation.
Zhou H; Wang DA; Baldini L; Ennis E; Jain R; Carie A; Sebti SM; Hamilton AD
Org Biomol Chem; 2006 Jun; 4(12):2376-86. PubMed ID: 16763682
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors.
Sun J; Wang DA; Jain RK; Carie A; Paquette S; Ennis E; Blaskovich MA; Baldini L; Coppola D; Hamilton AD; Sebti SM
Oncogene; 2005 Jul; 24(29):4701-9. PubMed ID: 15897913
[TBL] [Abstract][Full Text] [Related]
3. Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors.
Dai Y; Guo Y; Frey RR; Ji Z; Curtin ML; Ahmed AA; Albert DH; Arnold L; Arries SS; Barlozzari T; Bauch JL; Bouska JJ; Bousquet PF; Cunha GA; Glaser KB; Guo J; Li J; Marcotte PA; Marsh KC; Moskey MD; Pease LJ; Stewart KD; Stoll VS; Tapang P; Wishart N; Davidsen SK; Michaelides MR
J Med Chem; 2005 Sep; 48(19):6066-83. PubMed ID: 16162008
[TBL] [Abstract][Full Text] [Related]
4. PDGF-D, a new protease-activated growth factor.
LaRochelle WJ; Jeffers M; McDonald WF; Chillakuru RA; Giese NA; Lokker NA; Sullivan C; Boldog FL; Yang M; Vernet C; Burgess CE; Fernandes E; Deegler LL; Rittman B; Shimkets J; Shimkets RA; Rothberg JM; Lichenstein HS
Nat Cell Biol; 2001 May; 3(5):517-21. PubMed ID: 11331882
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms through which gangliosides inhibit PDGF-stimulated mitogenesis in intact Swiss 3T3 cells: receptor tyrosine phosphorylation, intracellular calcium, and receptor binding.
Yates AJ; VanBrocklyn J; Saqr HE; Guan Z; Stokes BT; O'Dorisio MS
Exp Cell Res; 1993 Jan; 204(1):38-45. PubMed ID: 8416794
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory DNA ligands to platelet-derived growth factor B-chain.
Green LS; Jellinek D; Jenison R; Ostman A; Heldin CH; Janjic N
Biochemistry; 1996 Nov; 35(45):14413-24. PubMed ID: 8916928
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy.
Pietras K; Rubin K; Sjöblom T; Buchdunger E; Sjöquist M; Heldin CH; Ostman A
Cancer Res; 2002 Oct; 62(19):5476-84. PubMed ID: 12359756
[TBL] [Abstract][Full Text] [Related]
8. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
[TBL] [Abstract][Full Text] [Related]
9. 3-amino-benzo[d]isoxazoles as novel multitargeted inhibitors of receptor tyrosine kinases.
Ji Z; Ahmed AA; Albert DH; Bouska JJ; Bousquet PF; Cunha GA; Diaz G; Glaser KB; Guo J; Harris CM; Li J; Marcotte PA; Moskey MD; Oie T; Pease L; Soni NB; Stewart KD; Davidsen SK; Michaelides MR
J Med Chem; 2008 Mar; 51(5):1231-41. PubMed ID: 18260617
[TBL] [Abstract][Full Text] [Related]
10. Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling.
Lamy S; Beaulieu E; Labbé D; Bédard V; Moghrabi A; Barrette S; Gingras D; Béliveau R
Carcinogenesis; 2008 May; 29(5):1033-41. PubMed ID: 18339683
[TBL] [Abstract][Full Text] [Related]
11. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of red and white wines on inhibition of the platelet-derived growth factor receptor: impact of the mash fermentation.
Sparwel J; Vantler M; Caglayan E; Kappert K; Fries JW; Dietrich H; Böhm M; Erdmann E; Rosenkranz S
Cardiovasc Res; 2009 Mar; 81(4):758-70. PubMed ID: 19074160
[TBL] [Abstract][Full Text] [Related]
13. Design of growth factor antagonists with antiangiogenic and antitumor properties.
Sebti SM; Hamilton AD
Oncogene; 2000 Dec; 19(56):6566-73. PubMed ID: 11426641
[TBL] [Abstract][Full Text] [Related]
14. A synthetic, bioactive PDGF mimetic with binding to both alpha-PDGF and beta-PDGF receptors.
Lin X; Takahashi K; Liu Y; Derrien A; Zamora PO
Growth Factors; 2007 Apr; 25(2):87-93. PubMed ID: 17852406
[TBL] [Abstract][Full Text] [Related]
15. [Platelet- derived growth factor--the construction, role and it's receptors].
Mantur M; Koper O
Pol Merkur Lekarski; 2008 Feb; 24(140):173-6. PubMed ID: 18634279
[TBL] [Abstract][Full Text] [Related]
16. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
Bran B; Bran G; Hörmann K; Riedel F
Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
[TBL] [Abstract][Full Text] [Related]
17. The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth.
Ehnman M; Li H; Fredriksson L; Pietras K; Eriksson U
Oncogene; 2009 Jan; 28(4):534-44. PubMed ID: 18997817
[TBL] [Abstract][Full Text] [Related]
18. Selection and characterization of small random transmembrane proteins that bind and activate the platelet-derived growth factor beta receptor.
Freeman-Cook LL; Dixon AM; Frank JB; Xia Y; Ely L; Gerstein M; Engelman DM; DiMaio D
J Mol Biol; 2004 May; 338(5):907-20. PubMed ID: 15111056
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family.
Reigstad LJ; Varhaug JE; Lillehaug JR
FEBS J; 2005 Nov; 272(22):5723-41. PubMed ID: 16279938
[TBL] [Abstract][Full Text] [Related]
20. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
